FindTrial
Sign In

Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19)

Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029549
Enrollment
Unknown
Registered
2020-02-04
Start date
2020-02-03
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Experimental group:Western medicine routine treatment combined with traditional Chinese medicine treatment
Control group:Western medicine routine treatment

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with suspected and confirmed diagnosis of 2019-nCoV Pneumonia Version 4.0 (published at 2020.01.27) of the National Health Commission

Exclusion criteria

Exclusion criteria: Exclude patients with severe and critical 2019-nCoV pneumonia

Design outcomes

Primary

MeasureTime frame
Severe conversion rate;Oxygenation index;2019-nCoV nucleic acid test;Chest CT;—

Countries

China

Contacts

Public ContactXie Chunguang

Hospital of Chengdu University of Traditional Chinese Medicine

xcg718@aliyun.com+86 18980880132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026